Consumer Health

Analgesics continued to see solid growth in current value terms in 2023, following the easing of most COVID-19-related restrictions in September 2022. With measures such as lockdowns, mandatory mask-wearing and social distancing no longer in place,…

Analgesics in Morocco has continued to develop positively in 2023, with total current value sales set to grow at a faster rate than in 2022 and most categories expected to post improved results in volume terms. Together with population growth and…

In late 2022 and into early 2023, a convergence of COVID-19, seasonal flu, and heightened influenza cases created what the media termed a "tripledemic," impacting Mexico, the US, and Central American nations. While Mexico did not experience the same…

The return of consumers to their busy-pandemic lifestyles had a positive impact on demand for analgesics in Malaysia in 2023. Within this, topical analgesics/anaesthetic remained the largest subcategory, as well as being the key driver of growth.…

Analgesics is failing to record a strong performance in Lithuania in 2023; following the pandemic years, sales are stagnating, reflecting the saturated market and consumer base. In addition, a growing scepticism and concern about the overreliance on…

Analgesics continues to witness strong current value growth in 2023 as consumers return to normal lifestyles and are exposed to regular seasonal common colds and viruses. A high proportion of analgesics are used to tackle everyday colds and flu…

Analgesics experienced a rise in unit prices due to inflationary pressure, which pushed up the price of imported medications and locally-produced options. Current value growth accelerated in 2023 as a result of this trend. Brand loyalty remains…

Analgesics is projected to continue to post fast retail volume growth over 2023. The potential for even higher growth is restricted by many households retaining stocks of analgesics purchased during the Coronavirus (COVID-19) pandemic. One clear…

Sales of analgesics in Japan have seen solid growth in current value terms in 2023 backed by increased opportunities for consumers to go out, the recovery in the number of inbound tourists, and a move away from the practice of wearing face masks on a…

Analgesics is expected to see a single-digit growth in current value terms in 2023. Sales are benefiting from the stable demand for analgesics and unit price increases linked to rising price lists as a result of the higher cost of production faced by…

The return to normal lifestyles out of the home is driving retail volume and current value sales of analgesics in 2023. Adults and children alike are more exposed to common colds and viruses requiring pain relief. Children in school are no longer…

Analgesics sales are returning to more normal patterns in 2023, following the fluctuations caused by the COVID-19 pandemic and the sharp price rises seen in 2022. On balance, current value growth rates are still elevated compared to pre-pandemic…

In the context of transforming the health system in Indonesia, one of the agendas currently being pursued by the Ministry of Health is to increase pharmaceutical resilience by increasing domestic production of the top 10 value medicines, which…

The driving force behind the growth of analgesics in India is the Millennial population, which includes those born between 1980 and 1994. This demographic, consisting of 328 million people, significantly drives demand for analgesics. The key reason…

As consumption patterns continue to stabilise following three years of pandemic-induced disruption, the majority of analgesics categories in Hungary are projected to contract in volume terms in 2023. Rates of decline in most look set to be modest,…

The reopened border between mainland China and Hong Kong in early 2023 had significant implications for the demand of analgesic remedies within the city, which rose considerably. This growth can be attributed to a shortage of analgesic remedies…

Analgesics is set to see a decline in sales in 2023 as consumers have migrated away from aspirin in an uncertain economic environment and sought to prioritise household essentials, while turning to other categories to treat basic ailments such as…

Upon the lifting of all COVID-19 related regulations, including the compulsory use of face masks, social distancing rules and compulsory self-isolation, there has been a surge in illness which has been a major contributor to sales growth for…

Consumption of analgesics continued to increase in Germany during 2023, after the demand spike in 2022, a year in which consumers were often experiencing flu and colds in the post-pandemic period and therefore OTC medicines, such as analgesics, were…

Analgesics is expected to register moderate constant value growth in 2023. High inflation is continuing to have an effect and consumers are expected to be highly price sensitive and prioritise value for money. That being said, inflation is easing in…